Computer Guided Versus Conventional TMJ Injection

Sponsor
Al-Azhar University (Other)
Overall Status
Completed
CT.gov ID
NCT05288647
Collaborator
(none)
40
1
2
21.6
1.9

Study Details

Study Description

Brief Summary

This study is designed to evaluate the clinical outcomes of computer-guided sodium hyaluronate injection in superior joint space in comparison to conventional injection for treatment of intra-articular TMJ disorder.

Condition or Disease Intervention/Treatment Phase
  • Procedure: TMJ injection
N/A

Detailed Description

This study aimed to reveal the superiority of computer-guided TMJ injection (if found) above the conventional method from the clinician and patient point of view.

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Efficacy of Computer-guided Versus Conventional Sodium Hyaluronate Injection in Superior Joint Space in Treatment of Intra-articular TMJ Disorder
Actual Study Start Date :
Dec 24, 2019
Actual Primary Completion Date :
Apr 7, 2021
Actual Study Completion Date :
Oct 11, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group A

Patients treated with four computer-guided sodium hyaluronate injections in superior TMJ space.

Procedure: TMJ injection
four sodium hyaluronate injections in superior TMJ space

Active Comparator: Group B

Patients treated with four conventional sodium hyaluronate injections in superior TMJ space.

Procedure: TMJ injection
four sodium hyaluronate injections in superior TMJ space

Outcome Measures

Primary Outcome Measures

  1. Comparison of maximum unassisted mouth opening range [6 months]

    Opening range determined by asking the patient to gently open the mouth and measure the distance between upper and lower central incisor using an vernier digital electronic caliper. Vertical movement of the mandible corrected by adding the vertical overlap.

  2. Comparison of modified Helkimo's clinical dysfunction index. [6 months]

    A modified version of Helkimo's clinical dysfunction index calculated to assess the TMJ dysfunction.

  3. Comparison of pain intensity on Visual analog scale [6 months]

    Patients asked to mark their TMJ-related pain level on a scale from 0 to 10, where 0 is "no pain" and 10 is "severe pain".

Secondary Outcome Measures

  1. Total procedural time. [Baseline]

    Total procedural time consumed starting from application of topical antiseptic up to the end of the procedure.

  2. Patient convenience. [Baseline]

    Patient convenience on a scale from "0" to "10", where "0" is highly convenient and "10" extremely intolerable.

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 40 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients diagnosed with intra-articular TMJ disorder according to Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD).

  • Patients who would not respond to conservative treatment as the first line of treatment.

Exclusion Criteria:
  • Patients with polyarthritis or degenerative joint disease.

  • Patients with myofascial pain.

  • Previous history of minimally invasive or invasive treatment of TMJ.

  • History of mandibular fracture.

  • Lactating, pregnant or planning pregnancy women.

  • Known hypersensitivity to hyaluronic acid or clear biocompatible photopolymer resin.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Faculty of Dentistry, Al-Azhar University. Cairo Egypt 11884

Sponsors and Collaborators

  • Al-Azhar University

Investigators

  • Principal Investigator: AbdElKader A Hyder, MSc, Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Al-Azhar University
  • Study Director: Wael A ElMohandes, PhD, Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Al-Azhar University
  • Study Director: Bahaa El-Din A Tawfik, PhD, Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Al-Azhar University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
AbdElKader Ahmed Hyder Mohamed, Principal Investigator, Al-Azhar University
ClinicalTrials.gov Identifier:
NCT05288647
Other Study ID Numbers:
  • CG-HA-TMJ-inj.
First Posted:
Mar 21, 2022
Last Update Posted:
Mar 31, 2022
Last Verified:
Mar 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by AbdElKader Ahmed Hyder Mohamed, Principal Investigator, Al-Azhar University

Study Results

No Results Posted as of Mar 31, 2022